...
首页> 外文期刊>The Rose Sheet: Toiletries, Fragrances and Skin Care >Infant Formula Woes Turn Perrigo’s Q2 Sour Despite Solid Americas’ OTC Sales
【24h】

Infant Formula Woes Turn Perrigo’s Q2 Sour Despite Solid Americas’ OTC Sales

机译:尽管美洲的OTC销售销量坚实

获取原文
获取原文并翻译 | 示例

摘要

Perrigo Co. PLC’s move to becoming an entirely consumer health, or “self care” frm hit a few bumps in its latest quar- ter as its infant formula revenues plunged on a recall and a loss of some customers and as its exit from the Rx generics market was delayed.
机译:Perrigo Co.PLC的举动成为一个完全是消费者的健康,或者“自我照顾”FRM在其最新Quarting中击中了一些颠簸,因为它的婴儿配方奶粉收入在召回和失去一些客户的损失并退出RX时 泛型市场被推迟了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号